Bionet

Taipei, Taiwan Founded: 1999 • Age: 27 yrs Listed
Cord blood banking service provider along with services on genetic testing

About Bionet

Bionet is a publicly listed company based in Taipei (Taiwan) founded in 1999. Cord blood banking service provider along with services on genetic testing. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Biorepository.

Company details

Bionet was founded in 1999 in Taipei, Taiwan, within the biotechnology sector. Cord blood banking services are offered alongside genetic testing. Operations extend to stem cell therapeutic applications, including peripheral blood and mesenchymal stem cells such as dental pulp stem cells. Cosmetic therapeutic applications using stem cells are under development. The company focuses on these areas for medical and research purposes.

  • Headquarters Taipei, Taiwan
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Website babybanks.com
  • Social LinkedIn YouTube
  • Legal Name Bionet Corp.
Key Metrics
  • Annual Revenue
    $1.24 B
    1.19
    as on Dec 31, 2025
  • Net Profit
    $51.43 M
    -38.56
    as on Dec 31, 2025
  • EBITDA
    $47.87 M
    -55.66
    as on Dec 31, 2025
  • Latest Funding Round
    $2.86M (USD), Post-IPO

    Mar 2009

  • Investors

Apps and channels of Bionet

its YouTube channel 訊聯生技 has 4.6K subscribers and 30 videos.

訊聯生技
YouTube 4.6K subscribers 30 videos Science & Technology
Open channel

Videos from Bionet

The most watched videos on Bionet's YouTube channel, 訊聯生技 (4.6K subscribers). Click a video to play it here.

BIONET Therapeutics | AI-Driven, Scalable Exosome Technology (with English subtitles)
107.3K views
2024再生醫學【外泌體醫美高峰論壇】-訊聯創Exosome Foundry新模式,助各行業同步升級 feat. 訊聯細胞智藥董事長 蔡政憲博士
74.8K views
訊聯細胞智藥外泌體製程-打造產業新標竿
42.6K views
傷口久不癒合怎麼辦?! 醫師解析治療新突破!feat. #張惇皓主任【為什麼!醫生】
32.4K views

More on 訊聯生技.

Funding Insights of Bionet

  • Total Rounds 1
  • Last Round Post-IPO — $2.86M
  • First Round $2.86M

    (Mar 2009)

  • Investors Count 1

All 1 funding rounds of Bionet with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2009$2.86MPost-IPO––
Valuation history

1 investors in total: 1 institutional.

Investors in Bionet

Bionet has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Foxconn Electronics.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Electronic products and components are manufactured globally by Foxconn.
1974foxconn.comTaipei, Taiwan
Premium access

Investor details for Bionet

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

IPO & Listings of Bionet

Bionet is a publicly listed company on the TPEX with ticker symbol 1784 in Taiwan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date29 Aug 2017
  • Listed onTT: 1784
  • Listed entityBionet Corp.
  • Exchange sectorHealth technology
  • ISINTW0001784007
  • Share price57.80 TWD · 2026-10-14
  • Market capitalisation2,925,869,635.00 TWD
  • Price to earnings50.8
  • EPS (diluted, trailing year)1.14 TWD
  • Dividend yield2.45%
  • Volume (last session)36,975

Financials of Bionet

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
20251.24B TWD51.4M TWD47.9M TWD
20241.22B TWD83.7M TWD108.0M TWD
20231.13B TWD78.4M TWD124.3M TWD
2022980.4M TWD38.0M TWD99.9M TWD
2021921.4M TWD26.6M TWD70.0M TWD
Premium access

Detailed financial statements for Bionet

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Bionet

3 dated milestones of Bionet across 18 years, from founding to its latest funding, stage changes and deals.

  1. Founded Bionet is founded.
  2. Funding First funding round of $2.9M.
  3. IPO Lists on the stock exchange (IPO).

Web traffic of Bionet

The website of Bionet (babybanks.com) receives about 2.6K visits a month.

  • Monthly visits
    2.6K

    ▲ 128.8% vs previous month

Similar websites

Websites whose visitors overlap most with Bionet. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
genovate-bio.com
71%
2.4K#12,185,295View details
vectorite.com.tw
60%
1.7KView details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Bionet

Bionet was founded in 1999 and raised its 1st funding round 10 years after it was founded.

Bionet is headquartered in Taipei, Taiwan.

Bionet was founded in 1999 in Taipei, Taiwan, within the biotechnology sector. Cord blood banking services are offered alongside genetic testing. Operations extend to stem cell therapeutic applications, including peripheral blood and mesenchymal stem cells such as dental pulp stem cells. Cosmetic therapeutic applications using stem cells are under development. The company focuses on these areas for medical and research purposes.

Yes, Bionet is publicly traded on TPEX under the ticker symbol 1784.

Bionet has 1 investor. Key investors include Foxconn Electronics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available